Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

NIRMATRELVIR AND RI

Active
SPE2DP-26-T-4168Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Paxlovid, containing nirmatrelvir and ritonavir tablets, is being procured under a government contract requiring 50 boxes, each containing 10 blister cards with three tablets per card—two 150 mg nirmatrelvir tablets and one 100 mg ritonavir tablet—providing a five-day supply at two daily doses per box. The product is manufactured by Pfizer Inc with NDC 00069-5321-30 and is regulated by the FDA, requiring confirmation through an EBS referral. Each box is a unit of issue, and the item has a fixed 36-month shelf life that cannot be extended, in compliance with TYPE I (CODE Q) standards. Packaging must meet MIL-STD-2073-1E and the Medical Marking Standard No. 1, superseding MIL-STD-129, with all units sealed in commercial containers to ensure safe transport and delivery. Shipment must be delivered FOB destination within 20 days to the Navy Expeditionary Central Facility in Williamsburg, VA, using the fastest traceable means, excluding parcel post, and must be palletized according to DLA packaging requirements. The contract includes strict quality and technical specifications referenced from the DLA Master List, with no variance allowed in quantity and inspection and acceptance occurring at the delivery point. The solicitation number is SPE2DP-26-T-4168, with a response deadline of July 22, 2026, and an original required delivery date of April 28, 2026.

General Info

50 boxes of Paxlovid, 10 blisters per box, 3 tablets each, 36-month shelf life, FOB destination, delivery by April 28, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

BLDG 4 D STREET, WILLIAMSBURG, VA, 23185, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4168 Medical Supply Chain Pharm FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
NIRMATRELVIR AND RI
NIRMATRELVIR AND RITONAVIR TABLETS
PAXLOVIDNIRMATRELVIR 300 GM RITONAVIR
100 MG. 10 BLISTER CARDS. EACH BLISTER
CARD CONTAINS 3 TABLETS: 2 NIRMATRELVIR
TABLETS (150 MG EACH) 1 RITONAVIR TABLET
(100 MG EACH). EACH BLISTER CARD CONTAINS
ONE DOSE (MUST TAKE ALL THREE TABLETS).
BOX CONTAINS 5 DAY SUPPLY OF TWO DAILY DOSES.
.
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
. UNIT OF ISSUE BOX OF 10 EA . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
BIDDER SHALL SPECIFY SOURCE AND
PART NUMBER BEING SUPPLIED.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. .
PFIZER INC 86491 P/N NDC00069-5321-30
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017354061 0001 BX 50.000
SPE2DP-26-T-4168
SECTION B
PR: 7017354061 PRLI: 0001 CONT’D
NSN/MATERIAL:6505017227590
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
V4582F
NAVY EXPEDITIONARY CENTRAL FACILITY
CENTRAL ISSUE FACILITY
BLDG 4 D STREET
WILLIAMSBURG VA 23185
US
SPE2DP-26-T-4168
SECTION B
PR: 7017354061 PRLI: 0001 CONT’D
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
V4582F
NAVY EXPEDITIONARY CENTRAL FACILITY
CENTRAL ISSUE FACILITY
BLDG 4 D STREET
WILLIAMSBURG VA 23185
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) V4582F6110M023
RDD: 777
PROJ: LP5 TP 2
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 06
DIC: A4A DIST: 9B ADV: 2A FC: P7
Need Ship Date:00/00/0000 Original Required Delivery Date:04/28/2026
SPE2DP-26-T-4168 NSN/Part Number: 6505-01-722-7590 Quantity: 50 BX Purchase Request: 7017354061QTY: 50 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
IODINE SOLUTION, STRONGThe contract specifies the procurement of Iodine Solution, Strong, formally known as Lugol’s Solution 5 Percent, packaged in a 500ml amber glass bottle containing 5 percent iodine and 10 percent potassium iodide. The item is designated with NSN 6505-01-706-4127 and is to be delivered in a single unit, with no quantity variance allowed, under a firm delivery deadline of 20 days from contract award. Packaging must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed in commercial containers designed to prevent damage or breakage during transit. The shipment must be transported using the lowest-cost carrier while ensuring safe and accepted delivery to the designated destination in APO AE 09853, with explicit prohibition against parcel post; fastest traceable freight methods are required. The item carries a non-extendable shelf life of 60 months as a TYPE I (Code S) item, and all packaging and marking must adhere to DLA packaging requirements and applicable medical standards. Delivery is FOB destination, with inspection and acceptance occurring upon arrival, and the supplier is required to meet technical and quality specifications referenced in the DLA Master List. The contract is issued under solicitation SPE2DP-26-T-4152, with a required delivery date of July 16, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
KETOROLAC TROMETHAMINEKetorolac Tromethamine Injection, USP 15 mg per mL in prefilled syringes, 24’s per unit, is being procured under contract SPE2DP-26-T-4143 for delivery to Fort Bragg, North Carolina, with a required delivery date of July 13, 2026, and a five-day delivery window. The item is identified by NSN 6505-01-666-2156 and NDC 76045-0107-10, manufactured by FRESENIUS KABI, LLC, and must comply with DLA’s Master List of Technical and Quality Requirements, including Packaging Requirement RP001 and Shelf-life requirement RS016, which mandates a non-extendable 24-month shelf life. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and units must be sealed in commercial containers that ensure protection from damage during transit. The product must be shipped by the fastest traceable means, excluding parcel post, and labeled according to current Hazard Communication Standards (29 C.F.R. 1910.1200), including OSHA-compliant Safety Data Sheets and labels, as mandated post-June 2015. The quantity is one unit of issue (PG), with zero variance permitted, and inspection and acceptance occur at the destination. Packaging and palletization must follow DLA specifications, and government identification must not appear on non-accepted supplies. The contract requires full compliance with all applicable DLA technical and quality requirements, which take precedence over ASTM D3951 or other general commercial standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOLBenzocaine and Menthol Lozenge, manufactured by RB Health US LLC and Reckitt Benckiser LLC, is a 15 mg benzocaine and 2.6 mg menthol oral pain reliever in honey lemon flavor, packaged in units of 16 lozenges, with a shelf life of 36 months that is non-extendable. The product must be stored at 20-25°C (68-77°F) and protected from humidity. All medical acquisitions require commercial packaging that ensures protection from damage or breakage, with each unit sealed in an appropriate container and shipped in exterior containers that guarantee safe, low-cost delivery to the destination. Material must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging must comply with DLA’s packaging requirements and palletization standards. The item is identified by NSN 6505017081449 and NDC 63824-0732-16, and is procured across five contract line items totaling 58 package units, each priced at $1.00 per unit, for total contract value of $58.00. Delivery is required within 20 days, FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring at the delivery point. Shipments must be traceable, excluding parcel post, and sent to designated military logistics addresses at Fort Bragg, North Carolina, and Fort Stewart, Georgia. The solicitation, issued by the Department of Defense under contract SPE2DP-26-T-4113, has a response deadline of July 20, 2026, and requires compliance with all technical and quality requirements listed in the DLA Master List.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 2 days
View Details
NAICS: 325411
New
DIBBS
ANALGESIC GEL, TOPICALThe contract specifies the procurement of an analgesic gel for topical use containing 5% menthol USP, supplied in 4 oz tubes with 144 tubes per case, classified as a flammable hazardous material requiring storage at 20–25°C (68–77°F) and protection from excessive heat or open flame. The item is identified by NSN 6505-01-658-7643 with a non-extendable shelf life of 24 months and must be packaged in commercial-grade containers that ensure protection from damage during transport, conforming to Medical Marking Standard No. 1 instead of MIL-STD-129. Shipment of the product must adhere to applicable hazard communication regulations, including the submission of Safety Data Sheets compliant with 29 C.F.R. 1910.1200 prior to award, and each shipment must include an accompanying SDS. Labels must meet OSHA’s revised Hazard Communication Standard aligned with the Globally Harmonized System, and supplier employees must be trained on these requirements. Packaging and transportation must comply with 49 CFR and ICAO regulations due to the flammable nature of the product, and all materials must be marked and documented in accordance with DLA’s hazardous material protocols, including electronic submission of SDS to DLA.MSDS@DLA.MIL. The contract is issued under solicitation SPE2DP-26-T-4115, requiring delivery within 20 days to Waterveciet, NY, and is managed by the Department of Defense’s Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100 mg in bottles of nine tablets, are being procured under solicitation SPE2DP-26-T-4080 for delivery to APO AE 09094-3219, with a required delivery date of July 14, 2026, and a lead time of 20 days. The item, identified by NSN 6505-01-727-8704, is intended for the acute treatment of migraine with or without aura in adults and must be stored at 20 to 25°C (68 to 77°F), protected from light, and maintained under USP controlled room temperature conditions. The contract mandates a strict shelf life of 24 months, non-extendable, in compliance with RS001 for a Type I (Code M) medical item, and requires labeling and marking in accordance with the latest edition of Medical Marking Standard No. 1 and MIL-STD-129, with packaging conforming to MIL-STD-2073-1E, Packing Level B, and DLA Packaging Requirements for Procurement (RP001). The item must be sourced from domestic origin unless otherwise indicated, and the supplier must provide the manufacturer’s part number, NDC 00378-5632-59 for Mylan Pharmaceuticals Inc. or NDC 51407-0013-09 for Golden State Medical Supply, Inc. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List of Technical and Quality Requirements, with additional compliance required for the removal of government identification from non-accepted supplies and covered defense information. The solicitation prohibits the use of additive manufacturing for this item and requires submission of a safety data sheet prior to award; failure to meet either requirement results in immediate disqualification. Contract administration requires the use of the Wide Area WorkFlow system for invoicing and receiving reports, with the contractor obligated to maintain current registration in the System for Award Management and provide commercial and government entity codes. The contract incorporates numerous Federal Acquisition Regulation clauses addressing equal opportunity, trafficking in persons, employment eligibility verification, sustainable products, hazardous materials identification, cybersecurity, changes, unenforceability of obligations, accelerated payments to small business subcontractors, safeguarding information systems, transportation by sea, disclosure of information, whistleblower rights, and notification
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

6 days ago

DEADLINE

in 2 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOLThe contract solicits 4 packaging units of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges, each containing 16 lozenges with 15 mg benzocaine and 2.6 mg menthol, identified by NSN 6505-01-708-1449 and NDC 63824-0732-16. The product must be stored at 20–25°C (68–77°F) and protected from humidity, with a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. All units must be individually sealed in commercial packaging that protects against damage or breakage, and shipped in commercial exterior containers ensuring safe, cost-effective delivery to Fort Bragg, NC, under FOB Destination terms. Medical Marking Standard No. 1 supersedes MIL-STD-129 for all labeling, and palletization must comply with DLA Packaging Requirements for Procurement. Delivery is required within five days of award, with inspection and acceptance occurring at the destination. The item falls under NAICS code 325411 and is subject to the Buy American Act, Berry Amendment, and DFARS 252.225-7001, requiring domestic sourcing. Contractors must comply with cybersecurity requirements including FAR 52.204-7012, NIST SP 800-171, and prohibitions on covered telecommunications equipment. Safety Data Sheets must be submitted if applicable, and all offerors must maintain active SAM registration. The contract includes clauses on whistleblower rights, information safeguarding, trafficking in persons, arbitration restrictions, and prohibitions on mandatory confidentiality agreements. Quotations must be submitted via email by July 20, 2026, and while the solicitation is not a small business set-aside, HUBZone price preferences may apply. The point of contact is James Foggie, and invoice and receiving reports must be processed through Wide Area Workflow unless an exception applies.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

6 days ago

DEADLINE

in 2 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 541690
New
DIBBS
Regulatory Compliance & Labeling ServicesThe contract requires the provision of regulatory consulting and labeling services to ensure pharmaceutical products comply with Department of Defense medical marking requirements and OSHA hazard communication standards. This subcontract is targeted at supporting the Medical Supply Chain Pharm FSA under the Department of Defense, with performance centered at Fort Stewart, Georgia, 31314-5185. The work involves interpreting and applying complex regulatory frameworks to labeling and documentation processes, ensuring that all medical pharmaceuticals meet federal safety and identification mandates for military use. Respondents must demonstrate expertise in DoD-specific medical labeling protocols and OSHA’s Globally Harmonized System for chemical hazard communication. The opportunity is open for a limited time, with a response deadline of July 22, 2026, and was posted on July 16, 2026, under NAICS code 541690 for other scientific and technical consulting services. No set-aside classification is specified, and the contract does not include details about the point of contact or specific award amount. Interested parties must access the full solicitation through the DIBBS portal using the provided link to submit proposals that align with the technical and compliance expectations outlined by the DoD. The focus is on accurate, auditable labeling systems that support safe handling, storage, and distribution of pharmaceuticals within military medical supply chains.
Other Scientific and Technical Consulting Services

POSTED

2 days ago

DEADLINE

in 4 days
View Details